2023 WMIF | A Deep Dive on Genetic Modalities for CNS Diseases: The Genetic Medicine Frontier

A Deep Dive on Genetic Modalities for CNS Diseases: The Genetic Medicine Frontier and Applications in CNS
A new era of precision medicine is upon us and has yielded some notable successes in key disease areas. Scientists are now pursuing this vision for diseases of the brain and spinal cord, harnessing biomarkers, molecularly targeted drugs, as well as gene and cell therapies aimed at the root causes of CNS diseases. This panel will feature a discussion of the major opportunities and challenges for the field.

Moderators
Merit Cudkowicz, MD
Chair, Department of Neurology, MGH; Julieanne Dorn Professor of Neurology, HMS
Aamir Mecklai
Managing Director, Healthcare Investment Banking, BofA Securities
Panelists

Janice Chen, PhD
Co-Founder & CTO, Mammoth Biosciences
Olivier Danos
EVP and Chief Scientific Officer, REGENXBIO
Zhen Li, PhD
President & CEO, ADARx Pharmaceuticals
Catherine Stehman-Breen, MD
CEO, Chroma Medicine
R. Nolan Townsend
CEO, LEXEO Therapeutics